329 related articles for article (PubMed ID: 14624074)
1. Advances in gene therapy and immunotherapy for brain tumors.
Kew Y; Levin VA
Curr Opin Neurol; 2003 Dec; 16(6):665-70. PubMed ID: 14624074
[TBL] [Abstract][Full Text] [Related]
2. Cell- and peptide-based immunotherapeutic approaches for glioma.
Yamanaka R
Trends Mol Med; 2008 May; 14(5):228-35. PubMed ID: 18403264
[TBL] [Abstract][Full Text] [Related]
3. Glioma-specific antigens for immune tumor therapy.
Skog J
Expert Rev Vaccines; 2006 Dec; 5(6):793-802. PubMed ID: 17184218
[TBL] [Abstract][Full Text] [Related]
4. [Brain tumors].
Hatano M; Mizuno M; Yoshida J
Gan To Kagaku Ryoho; 2003 Apr; 30(4):455-9. PubMed ID: 12722674
[TBL] [Abstract][Full Text] [Related]
5. Prospects and limitations of recombinant poxviruses for prostate cancer immunotherapy.
Hwang C; Sanda MG
Curr Opin Mol Ther; 1999 Aug; 1(4):471-9. PubMed ID: 11713762
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy for glioma: getting closer to the clinical arena?
Finocchiaro G; Pellegatta S
Curr Opin Neurol; 2011 Dec; 24(6):641-7. PubMed ID: 22027543
[TBL] [Abstract][Full Text] [Related]
7. Galectin-1 and immunotherapy for brain cancer.
Verschuere T; De Vleeschouwer S; Lefranc F; Kiss R; Van Gool SW
Expert Rev Neurother; 2011 Apr; 11(4):533-43. PubMed ID: 21469926
[TBL] [Abstract][Full Text] [Related]
8. Novel immunotherapeutic approaches to glioma.
Yamanaka R
Curr Opin Mol Ther; 2006 Feb; 8(1):46-51. PubMed ID: 16506525
[TBL] [Abstract][Full Text] [Related]
9. [Peptide vaccination therapy for malignant glioma].
Yamanaka R; Itoh K
Brain Nerve; 2007 Mar; 59(3):251-61. PubMed ID: 17370651
[TBL] [Abstract][Full Text] [Related]
10. Combinational adenovirus-mediated gene therapy and dendritic cell vaccine in combating well-established tumors.
Xia D; Moyana T; Xiang J
Cell Res; 2006 Mar; 16(3):241-59. PubMed ID: 16541123
[TBL] [Abstract][Full Text] [Related]
11. Dendritic cell-based immunotherapy for malignant gliomas.
Akasaki Y; Black KL; Yu JS
Expert Rev Neurother; 2005 Jul; 5(4):497-508. PubMed ID: 16026233
[TBL] [Abstract][Full Text] [Related]
12. Aspects of immunobiology and immunotherapy and uses of monoclonal antibodies and biologic immune modifiers in human gliomas.
Lee Y; Bigner DD
Neurol Clin; 1985 Nov; 3(4):901-17. PubMed ID: 2417097
[TBL] [Abstract][Full Text] [Related]
13. [Monoclonal immunotherapy with human monoclonal antibody(CLN-IgG) in glioma patients].
Kubo O; Takakura K
Nihon Rinsho; 2002 Mar; 60(3):497-503. PubMed ID: 11904965
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy for human glioma: innovative approaches and recent results.
Hussain SF; Heimberger AB
Expert Rev Anticancer Ther; 2005 Oct; 5(5):777-90. PubMed ID: 16221048
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapeutic approaches for the treatment of malignant melanoma.
Curiel-Lewandrowski C; Atkins MB
Curr Opin Investig Drugs; 2001 Nov; 2(11):1553-63. PubMed ID: 11763157
[TBL] [Abstract][Full Text] [Related]
16. Sensitization of malignant glioma to chemotherapy through dendritic cell vaccination.
Liu G; Black KL; Yu JS
Expert Rev Vaccines; 2006 Apr; 5(2):233-47. PubMed ID: 16608423
[TBL] [Abstract][Full Text] [Related]
17. Potential adenovirus-mediated gene therapy of glioma cancer.
Fu YJ; Du J; Yang RJ; Yin LT; Liang AH
Biotechnol Lett; 2010 Jan; 32(1):11-8. PubMed ID: 19784809
[TBL] [Abstract][Full Text] [Related]
18. Targeting epidermal growth factor receptor variant III: a novel strategy for the therapy of malignant glioma.
Sonabend AM; Dana K; Lesniak MS
Expert Rev Anticancer Ther; 2007 Dec; 7(12 Suppl):S45-50. PubMed ID: 18076318
[TBL] [Abstract][Full Text] [Related]
19. Virally mediated immunotherapy for brain tumors.
Agarwalla PK; Barnard ZR; Curry WT
Neurosurg Clin N Am; 2010 Jan; 21(1):167-79. PubMed ID: 19944975
[TBL] [Abstract][Full Text] [Related]
20. Gene therapy for high-grade glioma.
Iwami K; Natsume A; Wakabayashi T
Neurol Med Chir (Tokyo); 2010; 50(9):727-36. PubMed ID: 20885107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
